
zzso therapies are one of the zzso of the new generation of zzso drugs aimed at zzso molecular zzso Up until the beginning of this century, the general opinion was that targeted agents should show zzso activity when used as single zzso However, it has now become clear that much greater improvements in therapeutic activity may be achieved by combining the novel agents with conventional zzso therapies already in use in the zzso zzso is currently used to treat half of all cancer patients at some stage in their therapy, although the development of zzso is an ongoing zzso It is therefore reasonable to expect that any novel zzso agent which reaches the clinic will be used in combination with zzso The rationale for combining zzso in particular with zzso exists, as zzso has been shown to kill zzso zzso cells, suggesting that zzso zzso may zzso zzso cells to the effects of zzso Furthermore, targeting the zzso may paradoxically increase zzso within zzso thereby enhancing zzso zzso In this review we present an update on the use of zzso methods in combination with zzso 

